HCQ for Non Europeans With Mild to Severe UC
Condition: Ulcerative Colitis (Disorder) Interventions: Drug: Hydroxychloroquine; Drug: Mesalamine Sponsors: Icahn School of Medicine at Mount Sinai; Crohn's and Colitis Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2021 Category: Research Source Type: clinical trials
The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
Condition: 2019 Novel Coronavirus Interventions: Drug: HCQ01; Other: standard of care (SOC) for COVID-19 Sponsors: Ministry of Health Jordan; King Hussein Cancer Center; ACDIMA Biocenter; Amman Pharmaceutical Industries; Sana Pharmaceutical Industry Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2021 Category: Research Source Type: clinical trials